Dexchlorpheniramine

This article examines the use of Dexchlorpheniramine in clinical trials for various conditions. Dexchlorpheniramine is an antihistamine medication that has been studied for its effectiveness in treating allergic reactions, respiratory infections, sunburn, insect bites, and cognitive effects. The trials compare different formulations and combinations of Dexchlorpheniramine with other drugs to assess its efficacy and safety in managing symptoms across various health conditions.

Table of Contents

What is Dexchlorpheniramine?

Dexchlorpheniramine is a medication that belongs to a class of drugs called antihistamines. Specifically, it is an H1 receptor antagonist, which means it blocks the effects of histamine in the body[1]. Histamine is a substance naturally produced by your body that can cause allergy symptoms when released in large amounts. By blocking histamine, dexchlorpheniramine helps to relieve various allergy-related symptoms.

Uses and Conditions Treated

Dexchlorpheniramine is used to treat a variety of conditions, including:

  • Allergic Rhinitis: This is inflammation of the nasal passages caused by allergies, often referred to as “hay fever.” Dexchlorpheniramine can help relieve symptoms such as sneezing, runny nose, and itchy eyes[2].
  • Insect Bites: The medication can be applied topically (on the skin) to relieve itching and other symptoms associated with insect bites[3].
  • Sunburn: Topical forms of dexchlorpheniramine can be used to alleviate symptoms of mild to moderate sunburn, such as itching and burning sensations[4].
  • Viral Upper Respiratory Tract Infections: In some cases, dexchlorpheniramine is used in combination with other medications to relieve symptoms of viral infections affecting the upper respiratory system[5].
  • Cutaneous Hypersensitivity: This refers to various skin reactions caused by allergies or other triggers. Dexchlorpheniramine can help manage symptoms of these reactions[6].

Forms and Administration

Dexchlorpheniramine comes in several forms, depending on the condition being treated:

  • Oral Solution: Liquid form that can be taken by mouth, often used for children or adults who have difficulty swallowing tablets[7].
  • Tablets: Solid form for oral administration, typically used for adults[2].
  • Topical Preparations: These include creams, lotions, and gels that are applied directly to the skin for conditions like insect bites or sunburn[4][8].

The dosage and frequency of administration can vary depending on the specific condition being treated, the patient’s age, and the form of the medication. Always follow your healthcare provider’s instructions or the directions on the product label.

Combination Therapies

Dexchlorpheniramine is often used in combination with other medications to enhance its effectiveness or to treat multiple symptoms simultaneously. Some common combinations include:

  • Dexchlorpheniramine + Pseudoephedrine + Guaifenesin: This combination is used to treat symptoms of viral upper respiratory tract infections. Pseudoephedrine acts as a decongestant, while guaifenesin is an expectorant that helps loosen mucus[5].
  • Dexchlorpheniramine + Betamethasone: Betamethasone is a corticosteroid that helps reduce inflammation. This combination is used to treat various allergic conditions, including persistent allergic rhinitis[2].

Effectiveness and Clinical Trials

Several clinical trials have been conducted to evaluate the effectiveness of dexchlorpheniramine in various forms and combinations:

  • A study compared dexchlorpheniramine cream and lotion for sunburn relief, demonstrating their effectiveness in reducing symptoms like itching and burning[4].
  • Another trial investigated the use of dexchlorpheniramine gel versus cream for insect bite relief, showing both forms to be effective[9].
  • A study on persistent allergic rhinitis compared a combination of dexchlorpheniramine and betamethasone to other antihistamine combinations, evaluating their efficacy in reducing nasal symptoms[2].

These studies generally show that dexchlorpheniramine, either alone or in combination with other drugs, is effective in treating various allergic conditions and symptoms.

Side Effects and Safety

Like all medications, dexchlorpheniramine can cause side effects. Common side effects may include:

  • Drowsiness
  • Dry mouth
  • Dizziness
  • Headache

In topical forms, some people may experience skin irritation at the application site. It’s important to note that dexchlorpheniramine, especially in oral forms, may cause drowsiness and affect cognitive performance[10]. Therefore, caution should be exercised when driving or operating machinery while taking this medication.

Always consult with your healthcare provider before starting any new medication, including dexchlorpheniramine. They can provide personalized advice based on your specific health condition and any other medications you may be taking.

Condition Formulations Key Findings
Respiratory Infections Oral solution (with pseudoephedrine and guaifenesin) Compared to Dexchlorpheniramine alone for relief of allergic symptoms
Sunburn Cream, lotion, gel Non-inferiority trials comparing different formulations for symptom relief
Insect Bites Cream, lotion, gel Evaluated for relief of pruritus and other bite-related symptoms
Cognition Not specified Studied effects on memory, alertness, and sensory-motor processes
Allergic Rhinitis Oral solution, tablets (with corticosteroids) Compared to other antihistamine-corticosteroid combinations for efficacy
Cutaneous Rash Oral solution (with betamethasone) Compared to desloratadine-prednisolone combination in children

Ongoing Clinical Trials on Dexchlorpheniramine

  • Study on HUVR-CARTemis-1 Therapy for Patients with Relapsed Multiple Myeloma After Allogeneic Transplant Using a Drug Combination

    Recruiting

    1 1 1
    Spain
  • Infusion Study of ARI-0001 Cells for Patients with Resistant or Refractory CD19+ Acute Lymphoid Leukemia

    Recruiting

    1 1 1
    Spain
  • Study on Pioglitazone for Improving Kidney Health in Patients with ANCA-Associated Vasculitis

    Recruiting

    1 1 1
    France
  • Study on the Effects of Plitidepsin for Adults with Long COVID Symptoms

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Spain
  • Study of Plitidepsin Treatment for Adults with Post-COVID-19 Condition

    Not recruiting

    1 1
    Spain

Glossary

  • Dexchlorpheniramine: An antihistamine medication used to treat allergic reactions and symptoms related to various conditions.
  • Antihistamine: A type of drug that blocks the effects of histamine, a substance produced by the body during allergic reactions.
  • Allergic Rhinitis: Inflammation of the nasal passages caused by an allergic reaction, often resulting in symptoms like sneezing, itching, and runny nose.
  • Visual Analog Scale (VAS): A measurement tool used to help patients rate the intensity of certain sensations and feelings, such as pain or itching.
  • Erythema: Redness of the skin caused by increased blood flow, often associated with inflammation or skin irritation.
  • Pruritus: Severe itching of the skin, which can be a symptom of various skin conditions or allergic reactions.
  • Non-inferiority Trial: A type of clinical trial designed to demonstrate that a new treatment is not worse than a standard treatment by more than a specified margin.
  • Topical: Referring to a medication or treatment applied directly to a particular place on or in the body, often the skin.
  • P300 Latency: A measure of cognitive function related to decision-making speed, often used in studies of brain activity and information processing.

References

  1. https://clinicaltrials.gov/study/NCT03805035
  2. https://clinicaltrials.gov/study/NCT01720485
  3. https://clinicaltrials.gov/study/NCT00995397
  4. https://clinicaltrials.gov/study/NCT01085851
  5. https://clinicaltrials.gov/study/NCT01085721
  6. https://clinicaltrials.gov/study/NCT01529242
  7. https://clinicaltrials.gov/study/NCT01529229
  8. https://clinicaltrials.gov/study/NCT01237925
  9. https://clinicaltrials.gov/study/NCT01233934
  10. https://clinicaltrials.gov/study/NCT00846950